ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,740 | +4.4% | 300 | 0.0% | 0.00% | – |
Q2 2023 | $4,542 | +4.4% | 300 | 0.0% | 0.00% | – |
Q1 2023 | $4,350 | +8.8% | 300 | 0.0% | 0.00% | – |
Q4 2022 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | +25.0% | 300 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 509,023 | $7,706,608 | 60.04% |
MPM ASSET MANAGEMENT LLC | 4,425,784 | $67,006,370 | 32.86% |
5AM Venture Management, LLC | 4,408,379 | $66,742,858 | 16.63% |
StepStone Group LP | 761,277 | $11,525,734 | 2.13% |
TCG Crossover Management, LLC | 584,955 | $8,856,219 | 1.45% |
Redmile Group, LLC | 1,311,572 | $19,857,200 | 0.76% |
Nan Fung Group Holdings Ltd | 49,082 | $743,101 | 0.48% |
Baker Brothers Advisors | 4,865,819 | $73,668,500 | 0.43% |
Corton Capital Inc. | 18,067 | $273,534 | 0.13% |
MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,589,700 | 0.03% |